P.335Phenotypic and genomic characterization as predictors of DMD 45 to 55 multi-exon skipping therapy

Autor: Gargaun, E., Wahbi, K., Ben Yaou, R., Guibaud, M., Solé, G., Tiffreau, V., Laforêt, P., Parent, M., Husson, M., Bassez, G., Cuisset, J., Urtizberea, A., Eymard, B., Boland, A., Deleuze, J., Salgado, D., Khran, M., Levy, N., Blesius, A., Leturcq, F., Pietri-Rouxel, F.
Zdroj: In Neuromuscular Disorders October 2019 29 Supplement 1:S165-S165
Databáze: ScienceDirect